Literature DB >> 22877945

Pan-epicardial lineage tracing reveals that epicardium derived cells give rise to myofibroblasts and perivascular cells during zebrafish heart regeneration.

Juan Manuel González-Rosa1, Marina Peralta, Nadia Mercader.   

Abstract

Myocardial infarction (MI) leads to a severe loss of cardiomyocytes, which in mammals are replaced by scar tissue. Epicardial derived cells (EPDCs) have been reported to differentiate into cardiomyocytes during development, and proposed to have cardiomyogenic potential in the adult heart. However, mouse MI models reveal little if any contribution of EPDCs to myocardium. In contrast to adult mammals, teleosts possess a high myocardial regenerative capacity. To test if this advantage relates to the properties of their epicardium, we studied the fate of EPDCs in cryoinjured zebrafish hearts. To avoid the limitations of genetic labelling, which might trace only a subpopulation of EPDCs, we used cell transplantation to track all EPDCs during regeneration. EPDCs migrated to the injured myocardium, where they differentiated into myofibroblasts and perivascular fibroblasts. However, we did not detect any differentiation of EPDCs nor any other non-cardiomyocyte population into cardiomyocytes, even in a context of impaired cardiomyocyte proliferation. Our results support a model in which the epicardium promotes myocardial regeneration by forming a cellular scaffold, and suggests that it might induce cardiomyocyte proliferation and contribute to neoangiogenesis in a paracrine manner.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22877945     DOI: 10.1016/j.ydbio.2012.07.007

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  67 in total

Review 1.  Redirecting cardiac growth mechanisms for therapeutic regeneration.

Authors:  Ravi Karra; Kenneth D Poss
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 2.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

3.  Extracellular component hyaluronic acid and its receptor Hmmr are required for epicardial EMT during heart regeneration.

Authors:  Maria A Missinato; Kimimasa Tobita; Nicla Romano; James A Carroll; Michael Tsang
Journal:  Cardiovasc Res       Date:  2015-07-07       Impact factor: 10.787

Review 4.  Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.

Authors:  Katherine B Schuetze; Timothy A McKinsey; Carlin S Long
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

Review 5.  Cell migration during heart regeneration in zebrafish.

Authors:  Naoyuki Tahara; Michael Brush; Yasuhiko Kawakami
Journal:  Dev Dyn       Date:  2016-05-10       Impact factor: 3.780

6.  Fast revascularization of the injured area is essential to support zebrafish heart regeneration.

Authors:  Rubén Marín-Juez; Michele Marass; Sebastien Gauvrit; Andrea Rossi; Shih-Lei Lai; Stefan C Materna; Brian L Black; Didier Y R Stainier
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

7.  Dusp6 attenuates Ras/MAPK signaling to limit zebrafish heart regeneration.

Authors:  Maria A Missinato; Manush Saydmohammed; Daniel A Zuppo; Krithika S Rao; Graham W Opie; Bernhard Kühn; Michael Tsang
Journal:  Development       Date:  2018-03-06       Impact factor: 6.868

Review 8.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

Review 9.  The roles of endogenous retinoid signaling in organ and appendage regeneration.

Authors:  Nicola Blum; Gerrit Begemann
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 10.  Building and re-building the heart by cardiomyocyte proliferation.

Authors:  Matthew J Foglia; Kenneth D Poss
Journal:  Development       Date:  2016-03-01       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.